Physicians for Reproductive Health: SCOTUS Hears Oral Arguments in Mifepristone Case
March 27, 2024
March 27, 2024
NEW YORK, March 27 -- Physicians for Reproductive Health issued the following statement on March 26, 2024, by President and CEO Jamila Perritt:
* * *
Today, the Supreme Court of the United States heard oral arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine and Danco Laboratories v. Alliance for Hippocratic Medicine, which could threaten access to mifepristone, one of the medications used in medication abortion care.
Dr. Jamila P . . .
* * *
Today, the Supreme Court of the United States heard oral arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine and Danco Laboratories v. Alliance for Hippocratic Medicine, which could threaten access to mifepristone, one of the medications used in medication abortion care.
Dr. Jamila P . . .